Ravelcare made a stellar debut on the BSE SME platform on Monday, December 8. The stock opened at ₹201 per share, representing a 54.62% premium over its IPO price of ₹130. The strong listing reflects robust market interest and highlights the growing appeal of SME IPOs in the Indian stock market.
Market Performance
The debut session showcased a remarkable response from investors:
- Listing price: ₹201 per share
- IPO price: ₹130 per share
- Premium on debut: 54.62%
The listing underscores investor confidence in Ravelcare’s digital-first beauty and personal care model and its expansion strategy.
Main News: IPO Listing
Ravelcare’s SME IPO successfully concluded its public issue, opening on December 1 and closing on December 3, with allotments finalised on December 4.
- IPO size: ₹24.10 crore (fresh issue)
- Equity shares issued: 19 lakh shares
- Offer for sale: None.
The IPO proceeds are earmarked for specific growth initiatives:
- ₹11.5 crore for marketing and advertising to boost brand visibility
- ₹7.8 crore for a new manufacturing facility at Mauje-Peth in Amravati
- Remaining funds for general corporate purposes
The IPO witnessed exceptional subscription across investor categories:
- Overall subscription: 437.60x
- Retail portion: 463.13x
- Non-Institutional Investors (NIIs): 752.16x
- Qualified Institutional Buyers (QIBs): 155.91x
Investors placed bids for 54.04 crore shares against 12.35 lakh shares on offer, demonstrating strong demand.
Company Details
Founded in 2018, Ravelcare is a digital-first beauty and personal care brand offering an extensive range of haircare, skincare, and bodycare products. The company follows a direct-to-consumer (D2C) model, leveraging e-commerce marketplaces and quick-commerce platforms to reach customers efficiently.
- Omnichannel presence: India and international markets including the UAE, Australia, Canada, Germany, the US, and Saudi Arabia
- Revenue (FY25): ₹24.98 crore
- Profit After Tax (PAT) FY25: ₹5.25 crore
- Revenue (6 months ended Sept 30, 2025): ₹14.4 crore
- PAT (6 months ended Sept 30, 2025): ₹3.2 crore
Through its omnichannel approach and expanding product portfolio, Ravelcare has successfully tapped into growing consumer demand both domestically and globally.
Summary
Ravelcare’s SME IPO made an impressive debut at ₹201 per share, well above the IPO price of ₹130. The funds raised will support marketing initiatives, a new manufacturing facility, and general corporate needs. With a strong D2C presence, omnichannel reach, and steady revenue growth, Ravelcare is positioned to strengthen its footprint in the beauty and personal care SME segment in India and select global markets.
